The findings revealed that the proportions of CD45+ immune cells in the MDZ group were higher than those in the PBS group (Fig. 6B), indicating that the immunological infiltration of the tumor was increased following MDZ treatment. This evidence concerns the gene PTPRC and neoplasm.